CM
KZR

Caption Management’s Kezar Life Sciences KZR Stock Holding History

Caption Management’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,551
Closed -$209K – 1519
2023
Q3 		$209K Buy
17,551
+15,457
+738% +$274K ﹤0.01% 1091
2023
Q2 		$51.3K Buy
+2,094
New +$54.5K ﹤0.01% 1007
2022
Q4 		– Sell
-130
Closed -$11K – 1508
2022
Q3 		$11K Sell
130
-4,128
-97% -$401K ﹤0.01% 1441
2022
Q2 		$352K Buy
4,258
+3,458
+432% +$305K ﹤0.01% 1147
2022
Q1 		$133K Buy
+800
New +$115K ﹤0.01% 1313

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Caption Management's KZR Position: Q4 2023 in Review

Caption Management sold out of Kezar Life Sciences (KZR) in Q4 2023, closing a stake of 17,551 shares — an estimated $209K sold.

Caption Management first reported a position in KZR in Q1 2022 and held it in 5 quarters. The position peaked at $352K in Q2 2022. 81 funds tracked by Wall St. Rank hold KZR as of Q4 2023.

  • Caption Management reported no remaining Kezar Life Sciences position as of Q4 2023 after selling out during the quarter.
  • Caption Management sold 17,551 Kezar Life Sciences shares in Q4 2023, an estimated $209K.
  • Caption Management first reported a position in Kezar Life Sciences in Q1 2022 and held it in 5 quarters.
  • Caption Management's Kezar Life Sciences position peaked at $352K in Q2 2022.
  • 81 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q4 2023.

Based on Caption Management's 13F filing for Q4 2023, filed 14 Feb 2024.